How smart hospitals private equity performed in the pharmaceutical industry in Q2 2023

In value terms, smart hospitals-related deal activity remained flat in Q2 2023 compared with the previous quarter and as compared to Q2 2022. Related deal volume increased by 250% in Q2 2023 versus the previous quarter and was 600% higher than in Q2 2022.

The top-ranked financial advisors supporting these private equity deals in Q2 2023 were Clearwater International Ltd (France); Lazard; Rothschild & Co with 1, 1, 1 deals respectively.

The top-ranked legal advisors supporting these private equity deals in Q2 2023 were CMS Legal Services EEIG; Hogan Lovells International; McDermott Will & Emery with 1, 1, 1 deals respectively.

For further understanding of GlobalData’s Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry – Implications and Outlook – 2023 Edition, buy the report here.

Subscribe to our Newsletter

Get industry leading news, data and analysis delivered to your inbox

Subscribe

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Buyouts and Direct Investments done by Private Equity firms.